Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04906824 · ClinicalTrials.gov registry record
Post-Market Registry in Europe and US for the Use of VascuCelTM
A clinical trial of Great Vessel Reconstruction and Peripheral Vessel Reconstruction, sponsored by LeMaitre Vascular.
- Active
- Registry status
- 100
- Enrollment target
- 5
- Study locations
NCT04906824: Active study of Great Vessel Reconstruction and Peripheral Vessel Reconstruction, sponsored by LeMaitre Vascular.
NCT04906824 is a study of Great Vessel Reconstruction and Peripheral Vessel Reconstruction that is active but no longer recruiting, run by LeMaitre Vascular. The registered enrollment target is 100 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04906824, a study of Great Vessel Reconstruction and Peripheral Vessel Reconstruction, is active but no longer recruiting, sponsored by LeMaitre Vascular.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, peripheral vascular reconstruction or suture line buttressing. This registry will collect safety and performance data up to 2 years following implantation.
Primary Outcome
collect data on the number of incidence of graft related reintervention
Conditions Studied
Interventions
- DEVICE great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing
Study Locations (5)
Idaho
- Kootenai Health - Coeur d'Alene
Nevada
- Eddy Luh - Las Vegas
New York
- Westchester Medical Center - Valhalla
North Carolina
- University North Carolina - Chapel Hill
Other
- ASST Sette Laghi Varese - Varese
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2026-09 |
What the registry record for NCT04906824 still lists
NCT04906824 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Great Vessel Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing is the first listed.
NCT04906824 lists 5 locations in 5 states (Idaho, Nevada, New York).
Frequently Asked Questions
What is clinical trial NCT04906824 about?
NCT04906824 is a clinical study titled "Post-Market Registry in Europe and US for the Use of VascuCelTM". This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, peripheral vascular reconstruction or suture line buttressing. This registry will collect safety and perfor...
What is the current status of trial NCT04906824?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2023-06-09. Estimated completion is 2026-09.
What conditions does trial NCT04906824 study?
This clinical trial studies the following conditions: Great Vessel Reconstruction, Peripheral Vessel Reconstruction, Suture Line Buttressing.
What interventions are being tested in trial NCT04906824?
The interventions under investigation include: great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing (DEVICE).
Who is sponsoring clinical trial NCT04906824?
This trial is sponsored by LeMaitre Vascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04906824 being conducted?
This trial has 5 study locations across Idaho, Nevada, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI